These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37393447)

  • 21. Rectal cancer: MR imaging in local staging--is gadolinium-based contrast material helpful?
    Vliegen RF; Beets GL; von Meyenfeldt MF; Kessels AG; Lemaire EE; van Engelshoven JM; Beets-Tan RG
    Radiology; 2005 Jan; 234(1):179-88. PubMed ID: 15550372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application value of biplane transrectal ultrasonography plus ultrasonic elastosonography and contrast-enhanced ultrasonography in preoperative T staging after neoadjuvant chemoradiotherapy for rectal cancer.
    Xiao Y; Xu D; Ju H; Yang C; Wang L; Wang J; Hazle JD; Wang D
    Eur J Radiol; 2018 Jul; 104():20-25. PubMed ID: 29857861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rectal cancer staging: Multidetector-row computed tomography diagnostic accuracy in assessment of mesorectal fascia invasion.
    Ippolito D; Drago SG; Franzesi CT; Fior D; Sironi S
    World J Gastroenterol; 2016 May; 22(20):4891-900. PubMed ID: 27239115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
    Xu N; Huang FC; Li WL; Luan X; Jiang YM; He B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):359-365. PubMed ID: 33878826
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of the Extent of Mesorectal Invasion and Mesorectal Fascia Involvement in Patients with T3 Rectal Cancer With 2-D and 3-D Transrectal Ultrasound: A Pilot Comparison Study With Magnetic Resonance Imaging Findings.
    Liu M; Yin S; Li Q; Liu Y; Pei X; Han F; Li AH; Zhou J
    Ultrasound Med Biol; 2020 Nov; 46(11):3008-3016. PubMed ID: 32868155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy of high-resolution rectal magnetic resonance imaging re-staging with histopathology in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Laohawiriyakamol S; Worathanmanon S; Tubtawee T; Kanjanapradit K; Sangkhathat S; Pruphetkaew N; Chongsuvivatwong V
    Asian J Surg; 2021 Jan; 44(1):275-279. PubMed ID: 32712044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of MRI-detected extramural vascular invasion in stage T3 rectal cancer patients before neoadjuvant chemoradiation.
    Sun Y; Li J; Shen L; Wang X; Tong T; Gu Y
    Diagn Interv Radiol; 2018; 24(3):128-134. PubMed ID: 29770764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Locoregional staging using magnetic resonance imaging in rectal cancer: influence of diffusion-weighted imaging in the diagnostic accuracy.
    Fornell-Pérez R; Alemán-Flores P; Peralta GP; Rubio-García J; González-Domínguez MC; Aranda-Sánchez J; Vivas-Escalona V; Loro-Ferrer JF
    Cir Cir; 2020; 88(4):420-427. PubMed ID: 32567593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy.
    Kim SH; Lee JM; Hong SH; Kim GH; Lee JY; Han JK; Choi BI
    Radiology; 2009 Oct; 253(1):116-25. PubMed ID: 19789256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
    Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The split scar sign as an indicator of sustained complete response after neoadjuvant therapy in rectal cancer.
    Santiago I; Barata M; Figueiredo N; Parés O; Henriques V; Galzerano A; Carvalho C; Matos C; Heald RJ
    Eur Radiol; 2020 Jan; 30(1):224-238. PubMed ID: 31350587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative concurrent chemoradiotherapy MRI characteristics favouring pathologic complete response in patients with rectal cancer: Usefulness of MR T2-stage as an ancillary finding for predicting pathologic complete response.
    Lee HJ; Chung WS; An JH; Kim JH
    J Med Imaging Radiat Oncol; 2021 Apr; 65(2):166-174. PubMed ID: 33319450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application of magnetic resonance imaging in TN re-staging and efficacy evaluation after neoadjuvant therapy for rectal cancer].
    Lei J; Wang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jun; 21(6):637-641. PubMed ID: 29968238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRI for Rectal Cancer Primary Staging and Restaging After Neoadjuvant Chemoradiation Therapy: How to Do It During Daily Clinical Practice.
    Cianci R; Cristel G; Agostini A; Ambrosini R; Calistri L; Petralia G; Colagrande S
    Eur J Radiol; 2020 Oct; 131():109238. PubMed ID: 32905955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring MR regression patterns in rectal cancer during neoadjuvant radiochemotherapy with daily T2- and diffusion-weighted MRI.
    Bostel T; Dreher C; Wollschläger D; Mayer A; König F; Bickelhaupt S; Schlemmer HP; Huber PE; Sterzing F; Bäumer P; Debus J; Nicolay NH
    Radiat Oncol; 2020 Jul; 15(1):171. PubMed ID: 32653003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete Response Evaluation of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiotherapy Using Textural Features Obtained from T2 Weighted Imaging and ADC Maps.
    Azamat S; Karaman Ş; Azamat IF; Ertaş G; Kulle CB; Keskin M; Sakin RND; Bakır B; Oral EN; Kartal MG
    Curr Med Imaging; 2022; 18(10):1061-1069. PubMed ID: 35240976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of diffusion-weighted MRI in the diagnosis of T staging for rectal cancer].
    Lu Z; Qian W; Cao W; Yao H; Zhou X; Cao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Mar; 18(3):257-61. PubMed ID: 25809330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of adding dynamic contrast-enhanced MRI visual assessment to conventional MRI and clinical assessment in the diagnosis of complete tumour response to chemoradiotherapy for rectal cancer.
    Gollub MJ; Blazic I; Felder S; Knezevic A; Gonen M; Garcia-Aguilar J; Paty PP; Smith JJ
    Eur Radiol; 2019 Mar; 29(3):1104-1113. PubMed ID: 30242504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A prediction model of pathological complete response in patients with locally advanced rectal cancer after PD-1 antibody combined with total neoadjuvant chemoradiotherapy based on MRI radiomics].
    Zhang XY; Zhu HT; Li XT; Li YJ; Li ZW; Wang WH; Wu AW; Sun YS; Zhang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):228-234. PubMed ID: 35340172
    [No Abstract]   [Full Text] [Related]  

  • 40. Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer.
    Nahas SC; Nahas CSR; Cama GM; de Azambuja RL; Horvat N; Marques CFS; Menezes MR; Junior UR; Cecconello I
    Abdom Radiol (NY); 2019 Nov; 44(11):3632-3640. PubMed ID: 30663025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.